Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- $6.8M
- Net margin
- —
Little or no net debt.
- Total debt
- $12K
- Cash
- $1.2M
- Debt / equity
- 0.00
Owes more within a year than it holds to pay it.
- Current assets
- $1.3M
- Current liabilities
- $1.7M
- Current ratio
- 0.73
Consumes cash and must keep raising it.
- Operating cash flow
- -$456K
- Free cash flow
- -$456K
Not funding itself by issuing shares.
- Shares outstanding
- 19.2M
- Share growth (1y)
- -21.9%
- Cash runway
- 31 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
OACC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 261.96 K | 456.54 K | 255.50 K | 225.58 K | 269.81 K | 444.80 K |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 261.96 K | 456.54 K | 255.50 K | 225.58 K | 269.81 K | 444.80 K |
| Operating Income | -261.96 K | -456.54 K | -255.50 K | -225.58 K | -269.81 K | -444.80 K |
| Pretax Income | 1.60 M | 1.39 M | 1.79 M | 1.97 M | 1.87 M | 1.66 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 1.60 M | 1.39 M | 1.79 M | 1.97 M | 1.87 M | 1.66 M |
| EPS (Basic) | 0.07 | 0.06 | 0.07 | 0.08 | 0.08 | 0.07 |
| EPS (Diluted) | 0.07 | 0.06 | 0.07 | 0.08 | 0.08 | 0.07 |
| Shares Outstanding | 19.20 M | 19.20 M | 24.58 M | 19.20 M | 24.58 M | 24.58 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.